AstraZeneca pays insitro $40M upfront for AI drug discovery targeting cardiomyopathies and MASH. ImmunityBio's Anktiva gets ...
NorthStar/Quarkmed, Lonza/Qurient CDK7 deal, Triastek/J&J 3D printing pact, Scinai's $5.1M deal & HydRegen's $8M Series A led ...
New-to-me terms: Agents (for booking healthcare appointments and accessing patient portals) and abundance (the idea ...
Paul Stoffels’ new Armed Cell Therapeutics buys Lakefront’s (ex-Galapagos) preclinical CAR-T work for $9M upfront, $230M in ...
OMass has raised one of the largest private financings for a UK biotech in recent years as it seeks to follow in the ...
Sanofi's new R&D chief said on Wednesday Western drugmakers cannot ignore China's accelerating innovation and should consider ...
Verastem Oncology announced VS-7375 data showing 41% response rate in pancreatic cancer, raised $250M, and CEO Dan Paterson ...
FDA launches Rare Disease Framework Initiative to tailor reviews by disease, with a stakeholder meeting set for Oct. 28.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results